AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …

1Department of Cardiology, Division of Electrophysiology, University Heart Center Zurich,
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …

MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

Background The risk of stroke is heterogeneous across different groups of patients with atrial
fibrillation (AF), being dependent on the presence of various stroke risk factors. We provide …

Concepts and our approaches to stroke prevention in atrial fibrillation (AF) have changed
markedly over the last decade. There has been an evolution over the approach to stroke and …

Background: Stroke prevention with oral anticoagulants (OACs) is the cornerstone for the
management of atrial fibrillation (AF). However, data about the use of OACs among …

Atrial fibrillation (AF) is the most common sustained arrhythmia, causing a 2-fold increase in
mortality and a 5-fold increase in stroke. The Asian population is rapidly aging, and in 2050 …

The last decade has witnessed remarkable advances in pharmacological and
nonpharmacological strategies for stroke prevention in patients with atrial fibrillation …

Diabetes mellitus (DM) and essential hypertension are common conditions that are
frequently present together. Both are considered risk factors for cardiovascular disease and …

Background Oral anticoagulants (OACs) are not recommended for 'low-risk'patients with
atrial fibrillation (AF). We investigated the incidences of new risk factors developing, and the …